Shanghai Sanyou Medical Co Ltd

688085 · SHG · Healthcare / Medical Devices

13.07CNY+0.17 (+1.32%)

Price History

Full chart

Market Stats

Previous Close12.90

Open12.91

Day Range12.83 – 13.48

52-Week Range11.12 – 23.85

Volume3.86M

Market Cap4.86B

P/E (TTM)88.40

Forward P/E0.00

EPS0.15

Dividend Yield0.14%

Beta-0.08

50-Day Avg13.08

200-Day Avg15.59

About

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. It is also involved in production of ultrasonic power equipment and consumables. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and shoulder and elbow system, hip and pelvis system, knee joint system, foot and ankle, and palm and wrist systems. In addition, the company offers spinal implant, trauma implant consumables, ultrasonic power system products, and vertebral body shaping consumables. Further, it provides sports medicine and surgical equipment. Shanghai Sanyou Medical Co., Ltd. was founded in 2005 and is based in Shanghai, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEODr. Mingyan Liu
Employees562
HeadquartersJiading Industrial Zone, Shanghai, China, 201815, China
Websitehttps://www.sanyoumed.com

Leadership

Dr. Mingyan LiuChairman & Chief Scientist · b. 1957
Mr. Nong XuPresident, GM & Director · b. 1964

Financials

Income Statement

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	75.29M	139.97M	222.31M	354.32M	390.43M	593.36M	649.15M	460.39M	453.60M	542.79M
Growth (%)	-	+85.92%	+58.83%	+59.38%	+10.19%	+51.97%	+9.40%	-29.08%	-1.48%	+19.66%
Cost of Revenue	18.60M	34.31M	28.30M	35.46M	40.27M	63.61M	71.39M	103.81M	145.95M	136.21M
Gross Profit	56.68M	105.66M	194.02M	318.86M	350.17M	529.75M	577.77M	356.58M	307.65M	542.79M
Gross Margin	75.29%	75.49%	87.27%	89.99%	89.69%	89.28%	89.00%	77.45%	67.82%	100.00%
Operating Expense	55.55M	97.43M	125.66M	209.52M	219.79M	325.73M	348.67M	236.16M	286.58M	490.99M
Operating Income	1.13M	8.23M	68.36M	109.34M	130.38M	204.02M	229.09M	120.43M	21.07M	51.81M
Operating Margin	1.51%	5.88%	30.75%	30.86%	33.39%	34.38%	35.29%	26.16%	4.64%	9.54%
EBITDA	15.30M	14.55M	77.48M	120.48M	147.03M	230.68M	255.09M	161.17M	54.70M	86.32M
EBITDA Margin	20.33%	10.39%	34.85%	34.00%	37.66%	38.88%	39.30%	35.01%	12.06%	15.90%
Net Income	3.13M	5.20M	62.14M	97.82M	118.56M	186.37M	190.82M	95.58M	11.47M	63.29M
Net Income Margin	4.16%	3.72%	27.95%	27.61%	30.37%	31.41%	29.39%	20.76%	2.53%	11.66%
R&D	12.28M	12.76M	13.31M	18.45M	33.92M	56.55M	60.38M	65.22M	84.29M	83.71M
R&D as % of Total Revenue	16.31%	9.11%	5.99%	5.21%	8.69%	9.53%	9.30%	14.17%	18.58%	15.42%
Interest Expense	0	19.23K	22.97K	64.37K	45.93K	240.89K	288.22K	491.95K	2.53M	1.29M
Interest Expense % of Total Revenue	0.00%	0.01%	0.01%	0.02%	0.01%	0.04%	0.04%	0.11%	0.56%	0.24%

Balance Sheet

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	177.77M	335.83M	388.58M	551.48M	1.67B	2.00B	2.19B	2.26B	2.31B	2.38B
Total Liabilities	19.58M	46.78M	48.34M	113.67M	136.25M	260.90M	278.35M	218.80M	257.91M	252.14M
Total Equity	158.19M	289.07M	340.43M	437.81M	1.53B	1.69B	1.84B	1.92B	1.91B	2.10B
Cash	54.17M	34.43M	25.73M	37.45M	262.45M	382.31M	340.43M	654.35M	403.09M	335.65M
Total Debt	-	-	-	-	3.45M	5.07M	5.39M	4.99M	31.63M	-
Net Debt	-54.17M	-34.43M	-25.73M	-37.45M	-259.00M	-377.23M	-335.04M	-649.37M	-371.46M	-

Cash Flow

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	19.39M	21.54M	19.79M	61.72M	77.52M	144.92M	155.97M	267.43M	10.96M	67.99M
Investing Cash Flow	7.82M	-141.78M	-17.77M	-49.55M	-830.39M	12.36M	-156.15M	68.80M	-233.59M	-
Financing Cash Flow	-	100.49M	-10.78M	-494.90K	978.20M	-37.32M	-41.90M	-22.75M	-28.17M	-
Capital Expenditure	3.28M	36.62M	60.56M	79.69M	30.45M	91.66M	138.20M	25.94M	37.44M	28.91M
Free Cash Flow	16.10M	-15.08M	-40.77M	-17.97M	47.07M	53.26M	17.78M	241.50M	-26.47M	39.08M
Dividends Paid	-	10.78M	10.78M	35.86M	35.86M	35.73M	37.37M	19.20M	22.65M	2.14M
FCF to OCF	83.07%	-70.03%	-206.05%	-29.11%	60.72%	36.75%	11.40%	90.30%	-241.43%	57.48%
Dividend Paid to FCF	-	-71.47%	-26.44%	-199.58%	76.19%	67.08%	210.22%	7.95%	-85.56%	5.47%

Earnings

Report Date	Mar 27, 2020	Apr 22, 2020	Aug 19, 2020	Oct 21, 2020	Apr 23, 2021	Aug 9, 2021	Oct 24, 2021	Apr 25, 2022	Aug 22, 2022	Oct 26, 2022	Apr 24, 2023
EPS Estimate	0.00	0.00	-	-	-	-	-	-	-	-	-
EPS Actual	0.64	0.08	0.14	0.18	0.13	0.18	0.19	0.14	0.19	0.21	0.15
Surprise	-	-	-	-	-	-	-	-	-	-	-
Timing	Pre-market	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap4.86B

Enterprise Value4.34B

Trailing P/E88.40

Forward P/E0.00

Price / Sales8.58

Price / Book2.26

EPS0.15

Book Value5.84

Revenue (TTM)567.05M

Gross Profit (TTM)406.91M

EBITDA64.45M

Profit Margin9.57%

Operating Margin7.18%

Return on Equity1.54%

Return on Assets0.90%

Shares Outstanding366.81M

Shares Float230.41M

Beta-0.08

Dividend Yield0.14%

Dividend Rate0.02

Payout Ratio15.07%

Dividends

20231×

0.09Jun 5, 2023

20221×

0.17Jun 7, 2022

20211×

0.14Jun 11, 2021

Stock Splits

Jun 5, 202311:10
Jun 7, 202211:10